EU market access

Market Access

Europe’s new HTA reality: The JCA, one year on

Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.

Market Access

5 ways to address pricing and access challenges across the E...

In the feature ‘Successfully navigating the complexity of market access across Europe to improve health equity’, originally published in the European Biopharmaceutical Review, EVERSANA Gene

Views & Analysis

Grenoble, France – December 23, 2018: photography of French flag fluttering at La Bastille viewpoint. La Bastille is a fortress culminating at 476 m (1,561ft) above sea level, located at the south end of the Chartreuse mountain range and overlooking the city of Grenoble, France. The Bastille is the main tourist site of the Grenoble area with 600 000 visitors per year.

2021 market access prospects for France

In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring

Views & Analysis

2021 market access prospects for Spain

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain.

Views & Analysis

2021 market access prospects for Germany

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone prompts reflections on what has worked well and

Views & Analysis